Back to EUR-Lex homepage

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search
You are here

Document 62020TN0215

Kawża T-215/20: Rikors ippreżentat fil-21 ta’ April 2020 – Fidia farmaceutici vs EUIPO – Ioulia u Irene Tseti Pharmaceutial Laboratories (HYAL)

ĠU C 201, 15.6.2020, p. 48–49 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

15.6.2020   

MT

Il-Ġurnal Uffiċjali tal-Unjoni Ewropea

C 201/48

Rikors ippreżentat fil-21 ta’ April 2020 – Fidia farmaceutici vs EUIPO – Ioulia u Irene Tseti Pharmaceutial Laboratories (HYAL)

(Kawża T-215/20)

(2020/C 201/62)

Lingwa tar-rikors: l-Ingliż

Partijiet

Rikorrenti: Fidia farmaceutici SpA (Abano Terme, l-Italja) (rappreżentanti: R. Kunz-Hallstein u H. Kunz-Hallstein, avukati)

Konvenut: L-Uffiċċju tal-Proprjetà Intellettwali tal-Unjoni Ewropea (EUIPO)

Parti oħra quddiem il-Bord tal-Appell: Ioulia u Irene Tseti Pharmaceutial Laboratories SA (Ateni, il-Greċja)

Informazzjoni dwar il-proċedimenti quddiem l-EUIPO

Proprjetarju tat-trade mark kontenzjuża: ir-rikorrenti quddiem il-Qorti Ġenerali

Trade mark kontenzjuża kkonċernata: it-trade mark verbali tal-Unjoni “HYAL” –Trade mark tal-Unjoni Nru 2 430 221

Proċedimenti quddiem l-EUIPO: proċedimenti ta’ revoka

Deċiżjoni kkontestata: id-deċiżjoni tal-Ħames Bord tal-Appell tal-EUIPO tal-24 ta’ Jannar 2020 fil-Każ R 613/2019-5

Talbiet

Ir-rikorrenti titlob li l-Qorti Ġenerali jogħġobha:

—

tannulla d-deċiżjoni kkontestata;

—

tikkundanna lill-EUIPO għall-ispejjeż; alternattivament, jekk il-parti l-oħra quddiem il-Bord tal-Appell tintervjeni, tikkundanna lill-EUIPO u lill-intervenjenti in solidum għall-ispejjeż.

Motivi invokati

—

Ksur tal-Artikolu165(1) tar-Regolament (UE) 2017/1001 tal-Parlament Ewropew u tal-Kunsill;

—

Ksur tal-Artikoli 32(f) u 39(5) tar-Regolament delegat tal-Kummissjoni (UE) 2018/62;

—

Ksur tal-Artikolu 94(1) tar-Regolament (UE) 2017/1001 tal-Parlament Ewropew u tal-Kunsill;

—

Ksur tal-Artikolu 95(1) tar-Regolament (UE) 2017/1001 tal-Parlament Ewropew u tal-Kunsill;

—

Ksur tal-Artikolu 59(1) tar-Regolament (UE) 2017/1001 tal-Parlament Ewropew u tal-Kunsill;

—

Ksur tal-Artikolu 7(1)(c) tar-Regolament (UE) 2017/1001 tal-Parlament Ewropew u tal-Kunsill.
Top